Follow Us
Portfolio company and Correlation Ventures news. Data-driven insights on the VC industry. It's all here.
11.22.24
Read
Valora Therapeutics: Raises $30 Million Seed Financing from Top Investors to Transform Immunotherapy with a Novel Glyco-immune Checkpoint Platform
04.25.23
Mirvie: Publication of the Preeclampsia Prevention Care Plan, the first-ever actionable, evidence-based care plan for the prevention of preeclampsia.
04.13.23
Candesant Bio: Announcing the FDA clearance of BRELLA™ SweatControlPatch™
01.26.23
Foro: Emerges From Stealth Mode to Democratize Access to Capital For Mid-Size Businesses
01.25.23
Angle Health: Raises $58 Million To Modernize Access to Comprehensive Healthcare Benefits
01.18.23
Trefoil Therapeutics: Announces First Patient Dosed in Phase 1 Study of TTHX1114 for Treatment of Corneal Epithelial Defects
11.02.22
Overtime: Amazon Buys Rights For Teen Basketball League Overtime Elite—Expanding Further Into Live Sports
09.29.22
Trefoil Therapeutics: Announces Positive TTHX1114 Phase 2 Study Data
09.13.22
Tract: Raises $7M to help Teachers Empower Kids to Develop 21st Century Skills through Content Creation
05.17.22
Mirvie: Raises $60 Million For Blood Test To Predict Pregnancy Complications
02.10.22
EasyKnock: Home sale-leaseback startup EasyKnock raises $57 million
02.07.22
Good Eggs: Promises fresher grocery delivery in Los Angeles
02.04.22
Mirvie: Data Presented at SMFM 2022 Shows The Mirvie RNA Platform is First to Reveal The Underlying Biology of Preterm Birth
02.01.22
Angle Health: Mark Morgan joins Angle Health’s Board of Directors
01.05.22
Mirvie: Can Predict Pregnancy Complications Months Before They Happen Using New, Proprietary RNA Platform
12.01.21
Trefoil Therapeutics: Announces Third Tranche of $28 Million Series A Financing Based on Achievement of Clinical Trial Objectives
Categories
